Skip to main content

Table 2 Details of rapid aCGH results of aneuploid blastocysts derived from 8 patients for fresh SET and 13 patients for vitrified ET

From: A pilot proof-of-principle study to compare fresh and vitrified cycle preimplantation genetic screening by chromosome microarray and next generation sequencing

Case no. Total no. of aneuploid blastocysts Single chromosomal abnormality [Single chromosome loss/Single chromosome gain/Single segmental aneuploidy] Dual chromosomal abnormality Complex chromosomal abnormality
I. Fresh SET
1 9 4 (44.4 %) [1/2/1] 2 (22.2 %) 3 (33.3 %)
2 5 3 (60.0 %) [1/1/1] 0 (0 %) 2 (40.0 %)
3 11 2 (18.2 %) [1/0/1] 5 (45.5 %) 4 (36.4 %)
4 8 3 (37.5 %) [0/0/3] 1 (12.5 %) 4 (50.0 %)
5 6 4 (66.7 %) [3/0/1] 0 (0 %) 2 (33.3 %)
6 4 2 (50.0 %) [0/0/2] 2 (50.0 %) 0 (0 %)
7 1 1 (100.0 %) [0/0/1] 0 (0 %) 0 (0 %)
8 2 1 (50.0 %) [1/0/0] 0 (0 %) 1 (50.0 %)
Overall 46 20 (43.5 %) [7/3/10] 10 (21.7 %) 16 (34.8 %)
II. Vitrified ET
1 2 1 (50.0 %) [1/0/0] 0 (0 %) 1 (50.0 %)
2 3 2 (66.7 %) [0/0/2] 1 (33.3 %) 0 (0 %)
3 1 1 (100.0 %) [0/0/1] 0 (0 %) 0 (0 %)
4 4 2 (50.0 %) [1/1/0] 1 (25.0 %) 1 (25.0 %)
5 1 1 (100.0 %) [0/1/0] 0 (0 %) 0 (0 %)
6 1 1 (100.0 %) [0/0/1] 0 (0 %) 0 (0 %)
7 1 1 (100.0 %) [0/0/1] 0 (0 %) 0 (0 %)
8 3 2 (66.7 %) [0/0/2] 0 (0 %) 1 (33.3 %)
9 3 1 (33.3 %) [1/0/0] 1 (33.3 %) 1 (33.3 %)
10 0 0 (0 %) [0/0/0] 0 (0 %) 0 (0 %)
11 0 0 (0 %) [0/0/0] 0 (0 %) 0 (0 %)
12 2 1 (50.0 %) [1/0/0] 0 (0 %) 1 (50.0 %)
13 1 0 (0 %) [0/0/0] 0 (0 %) 1 (100.0 %)
Overall 22 13 (59.1 %) [4/2/7] 3 (13.6 %) 6 (27.3 %)